Morano, F., Lebbe, C., Cornfeld, M., Bhatia, S., Burgess, M., Grignani, G., . . . Yeung, C. C. S. Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201). BMJ Publishing Group.
Chicago Style (17th ed.) CitationMorano, Federica, et al. Phase II Study of Retifanlimab in Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma (POD1UM-201). BMJ Publishing Group.
MLA (9th ed.) CitationMorano, Federica, et al. Phase II Study of Retifanlimab in Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma (POD1UM-201). BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.